Physician

Henry Palangdao Igid, MD

According to 2025 Medicare claims, Henry Igid, MD (NPI: 1003182106) practices hematology/oncology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (NPI: 1598770471; TIN: 88-0350180) and primary practice location at 89144-9998.

Igid's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 706 traditional Medicare patients, billed 268,307 HCPCS/CPT codes, and received $4,059,334 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,036 prescription claims across 178 beneficiaries totaling $4,536,504 in drug costs, led by Ayvakit (Avapritinib). DME data shows 49 claims. Open Payments data shows 145 records totaling $8,914. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $62,396 to $4,059,334. Similarly, Part D prescription costs have risen steadily, from $54,492 to $4,536,504. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.1M2018 Medicare payment: $62,396 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,488,324 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,869,330 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,964,685 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,872,511 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,895,578 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,059,334 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181056,507$62,396
2019607201,562$2,488,324
2020582221,915$2,869,330
2021653287,669$3,964,685
2022704253,054$3,872,511
2023734216,886$2,895,578
2024706268,307$4,059,334

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.3M$4.5M2015 Drug cost: $54,492 (USD; Tot_Drug_Cst)2016 Drug cost: $6,497 (USD; Tot_Drug_Cst)2017 Drug cost: $19,427 (USD; Tot_Drug_Cst)2018 Drug cost: $143,364 (USD; Tot_Drug_Cst)2019 Drug cost: $704,891 (USD; Tot_Drug_Cst)2020 Drug cost: $1,645,250 (USD; Tot_Drug_Cst)2021 Drug cost: $1,340,989 (USD; Tot_Drug_Cst)2022 Drug cost: $1,127,122 (USD; Tot_Drug_Cst)2023 Drug cost: $2,424,683 (USD; Tot_Drug_Cst)2024 Drug cost: $4,536,504 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201598665$54,492
20163381$6,497
201735121$19,427
201839108$143,364
201985373$704,891
2020113692$1,645,250
2021128749$1,340,989
2022160806$1,127,122
2023158882$2,424,683
20241781,036$4,536,504

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$1.8K$3.6K2020 Medicare payment: $3,595 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $269 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $2,522 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R48$3,595
2021N/R14$269
2022N/RN/RN/R
2023N/RN/RN/R
2024N/R49$2,522

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more310606$96
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's323748$13
80053Blood test, comprehensive group of blood chemicals233907$10
36415Insertion of needle into vein for collection of blood sample264887$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count2651,098$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
AyvakitAvapritinib11330$424,695
JakafiRuxolitinib Phosphate22660$418,168
TagrissoOsimertinib Mesylate25750$414,022
PomalystPomalidomide11308$290,242
CabometyxCabozantinib S-Malate11330$283,263

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
K0823Power wheelchair, group 2 standard, captains chair, patient weight capacity up to and including 300 poundsYN/R12$1,624
J8530Cyclophosphamide; oral, 25 mgNN/R11$421
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R14$263
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R12$213

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.143$3,639Daiichi Sankyo Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.2$5,275PFIZER INC.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Henry Palangdao Igid, MD?

Tedicare shows public-source Medicare data for Henry Palangdao Igid, MD (NPI 1003182106), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Henry Palangdao Igid, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Henry Palangdao Igid, MD?

Henry Palangdao Igid, MD is linked to ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (billing NPI 1598770471) in the available physician profile data.

Does Henry Palangdao Igid, MD have Open Payments data?

Henry Palangdao Igid, MD has 145 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.